Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classement en actions #20515
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Prix de l'action
$20.38
Capitalisation boursière
$129.09M
Changement (1 jour)
-0.82%
Changement (1 an)
80.91%
Pays
PL
Échange Captor Therapeutics Spolka Akcyjna (CTX)

Catégorie

Historique des divisions d’actions pour Captor Therapeutics Spolka Akcyjna (CTX)
L’action Captor Therapeutics Spolka Akcyjna (symbole : CTX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 24, 2026.
Une action CTX achetée avant le Aug 24, 2026 équivaudrait aujourd’hui à 0 actions CTX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH